For more information about our care redesign solutions, contact us here.
As reimbursement models change, providers must strategically rethink how they approach care delivery. This can be a daunting task, but it’s essential for organizations that want to secure their market position and seize opportunities for improved financial success.
An expertly planned and managed care redesign effort can yield a better market position, a more effective care team, improved clinical outcomes, higher levels of patient and provider satisfaction, and reduced use and costs. That’s the good news. The more difficult message is this: achieving the benefits of a care redesign effort requires transforming strategy and approach. It’s easy to get off track or to simply delay starting.
We can help. Our approach is built on almost two decades of proven strategies developed by Geisinger Health System, an organization nationally recognized for effective innovations in care delivery. With a practical, real-world base of expertise, we can strategically accelerate your care redesign process so you achieve the desired outcomes faster, more efficiently, and more reliably than with other approaches.
We help you get started on care redesign by developing an understanding of your strategic objectives. We then perform a systematic baseline assessment of your current state. This assessment allows us to identify critical gaps that will inform our action plan.
Once we agree on next steps, the focus is all about practical implementation.
In the acute care environment (see ProvenCare Acute), this includes the following:
In the chronic and preventive care environment, (see ProvenCare Chronic & Prevention), implementation includes the following:
In our advanced patient-centered medical home environment (see ProvenHealth Navigator), implementation focuses on the following:
We’re proud of our track record of success in care redesign. It’s the core of who we are and why we’re viewed as the differentiated leaders in healthcare transformation.
For more information about our care redesign services, contact Andrew Blackmon.
Chief Technology Officer
Chief Technology Officer Mike Bertrand is a seasoned software executive with nearly three decades of experience leading the design and development of enterprise healthcare software solutions for hospitals, health systems and healthcare advisory firms.
Before joining xG Health, Mike was vice president of product development for HealthWyse, a leading provider of software solutions for the home healthcare industry. While at HealthWyse, he built and managed a highly regarded development group that was responsible for designing and delivering the leading mobile product for home healthcare professionals.
Previously, Mike spent more than eight years at PatientKeeper, a provider of EHR application integration platforms. As vice president of software development, he led the design and delivery of a large portion of the PatientKeeper product suite. Most notably he spearheaded the design and delivery of PatientKeeper’s computerized physician order entry (CPOE) application, which was voted “Best in KLAS” by KLAS, a leading healthcare research and insights firm. Before joining PatientKeeper, Mike also served as the director of software development for McKesson Corp. and as a software consultant at the Dana-Farber Cancer Institute.
Mike earned his bachelor’s degree in computer science from Westfield State University in Westfield, Massachusetts.
Andrew Blackmon, MBA, MHS
Chief Sales and Business Development Officer
Chief Sales and Business Development Officer Andrew Blackmon, MBA, MHS, has more than 18 years of experience in healthcare product sales, marketing, and strategy.
Before joining xG Health, Andrew was vice president of sales for population health and risk management solutions at McKesson. He came to McKesson through acquisition of MedVentive, an early population health vendor. Before MedVentive, he served as vice president of enterprise solutions development at MedAssets. He is a past president of the Georgia chapter of HIMSS, and he has held strategy and planning positions at PricewaterhouseCoopers and Orlando Health.
Andrew has an MBA and a Master’s of Health Science from the University of Florida Warrington, College of Business, and a Bachelor of Arts degree in Psychology from Rollins College.
Holly Barbella, RN, MBA
Risk Coordinator, Geisinger Health System
fuvb ekfhve v
Earl P. Steinberg, MD, MPP
Chief Executive Officer
Earl P. Steinberg, MD, MPP, is a nationally recognized expert in healthcare quality improvement and serves as xG Health’s chief executive officer. Earl also is an adjunct professor of Medicine and of Health Policy and Management at Johns Hopkins University and a member of Blue Cross/Blue Shield Association’s National Medical Advisory Panel.
Before joining xG Health, Earl was executive vice president of Innovation & Dissemination, and chief, Healthcare Solutions Enterprise at Geisinger Health System.
Before joining Geisinger, he was senior vice president for Clinical Strategy, Quality & Outcomes at WellPoint, Inc., the largest commercial health insurer by membership in the US, and president and CEO of Resolution Health Inc. (RHI), a leading healthcare data analysis company that provides innovative quality improvement and cost reduction services to health plans, employers, pharmacy benefit managers, and disease management companies.
Before joining RHI, Earl spent six years as vice president of Covance Health Economics and Outcomes Services Inc., director of its Quality Assessment and Improvement Systems Division, and co-director of its Outcomes Studies Group. He also spent 12 years on the full-time faculty at Johns Hopkins University, where he was professor of Medicine and of Health Policy and Management and director of the Johns Hopkins Program for Medical Technology and Practice Assessment, and four years on the Federal Physician Payment Review Commission. He co-chaired the Institute of Medicine’s panel on Standards for Development of Trustworthy Practice Guidelines.
Earl has received many awards, including the Henry J. Kaiser Family Foundation Faculty Scholar Award in General Internal Medicine (1984), the “Outstanding Young Investigator” Award from the Association for Health Services Research (1988), and a Special Presidential Visionary Award from the National Kidney Foundation (NFK) (2004) for his work as the scientific director of the NKF’s landmark Kidney Disease Outcomes and Quality Initiative, which produced more than 250 clinical practice guidelines for management of patients with end-stage renal disease. He also is a fellow of both the American College of Physicians and AcademyHealth, and he has published more than 125 articles in peer-reviewed journals.
Earl received his AB from Harvard College (summa cum laude), his medical degree from Harvard Medical School, and a Master of Public Policy from the Kennedy School of Government. He performed his residency training in internal medicine at Massachusetts General Hospital.